SATURN: A European, Prospective, Multicentre Registry for Male Stress Urinary Incontinence Surgery

Abstract

Surgery for male incontinence with artificial urinary sphincters and slings (SATURN) is a prospective, multicentre registry (observational cohort) for male stress urinary incontinence surgery to collect prospective data from multiple European centres and surgeons, to evaluate the short- and long-term success and the impact on quality of life.

Keywords: Implant; Males; Postprostatectomy incontinence; Registry; Stress urinary incontinence; Surgery.

Fig. 1

Twenty-eight centres included 1039 patients, who underwent surgery for male stress urinary incontinence. Belgium: University Hospitals Leuven (200 patients), Universitair Ziekenhuis Gent (14), Jessa Ziekenhuis Hasselt (64), AZ Groeninge Kortrijk (16), and Universitair Ziekenhuis Antwerpen (6). Spain: Hospital Universitario Puerta De Hierro-Majadahonda Madrid (31), Hospital Universitario 12 Octubre Madrid (57), Hospital Universitario de Canarias Tenerife (16), Hospital Universitario Virgen de las Nieves Granada (12), Hospital Universitari Germans Trias i Pujol Barcelona (20), Hospital General Universitario Gregorio Marañón Madrid (two), University Hospital La Fe Valencia (11), Hospital Universitario Ramón y Cajal Madrid (17), Hospital General Morales Meseguer Murcia (32), and Hospital La Paz Madrid (12). The Netherlands: Radboud University Medical Centre Nijmegen (133) and University Medical Centre Utrecht (48). Norway: Rikshoptitalet Oslo (148) and UNN Narvik (19). Czech Republic: Thomayer Hospital Prague (57). Italy: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (54). UK: Royal National Orthopaedic Hospital (nine), CUH – Addenbrooke’s Hospital Cambridge (26), and Guy’s & Thomas’ Hospital London (19). Germany: University Hospital Mainz (two), University Hospital Münster (four), and University Medical Center Hamburg Eppendorf (three). Finland: Helsinki University Central Hospital (seven).

Fig. 2

Flowchart showing the study inclusion and exclusion criteria.

Fig. 3

The flowchart shows the moments in follow-up with a maximum of 10 yr when patients are contacted by questionnaires regarding continence, 24-h pad weight test, and PROMS (EQ-5D-5L and ICIQ-UI SF), or data are derived from patients’ files during the interval concerning complications and revisions. AUS = artificial urinary sphincter; EQ-5D-5L = European Quality of Life 5 Dimensions 5 Level; ICIQ-UI SF = International Consultation on Incontinence Questionnaire—Urinary Incontinence Short Form; PROMS = patient-reported outcome measures; SUI = stress urinary incontinence.

Fig. 4

Twenty-four-hour pad test: a mean and median of, respectively, 523 and 400 g/24 h, taking all devices into account. The distribution of the pad test per device is shown in here. Patients receiving an artificial urinary sphincter prosthesis (AMS800, Victo [plus] or ZSI 375) had a clinically relevant higher leakage weight compared to other devices.